Assessing the Effect of Cardiac Gene Therapy Using Catheter-Based Pressure-Volume Measurement in Large Animals.
Tomoki SakataRenata MazurekSpyros A MavropoulosFrancisco J RomeoAnjali J RavichandranKiyotake IshikawaPublished in: Methods in molecular biology (Clifton, N.J.) (2022)
Gene therapy for heart failure targets various pathways that modulate cardiac function. Its detailed evaluation is crucial for proving the efficacy of cardiac gene therapies. Parameters that can be obtained by noninvasive approaches are generally influenced by loading conditions of the heart. In contrast, catheter-based left ventricular pressure-volume assessment provides a unique option to minimally invasively assess intrinsic myocardial function in a load-insensitive manner. In this chapter, we describe procedural steps for performing pressure-volume measurements and analysis in a preclinical large animal model.
Keyphrases
- gene therapy
- left ventricular
- heart failure
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- acute myocardial infarction
- aortic stenosis
- left atrial
- mitral valve
- atrial fibrillation
- genome wide
- magnetic resonance
- copy number
- stem cells
- gene expression
- computed tomography
- transcatheter aortic valve replacement
- acute heart failure